ABBV-295
A Study to Assess Adverse Events, Tolerability, and Pharmacokinetics of Subcutaneous Injections of ABBV-295 in Healthy Adult Japanese Participants With Overweight or Obesity.
AbbVie · Phase 1 · Active, not recruiting · Enrollment 24
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| ABBV-295 Part 1 | Healthy Volunteer | n/r | n/r | n/r | n/r |
| Placebo for ABBV-295 Part 1 | Healthy Volunteer | n/r | n/r | n/r | n/r |
| ABBV-295 Part 2 | Healthy Volunteer | n/r | n/r | n/r | n/r |
| Placebo for ABBV-295 Part 2 | Healthy Volunteer | n/r | n/r | n/r | n/r |